Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amino Acid Metabolism in Infants
- Conditions
- Preterm Infants
- Registration Number
- NCT02066610
- Lead Sponsor
- Abbott Nutrition
- Brief Summary
The objectives of the study were to assess the serum selenium, zinc, and copper status and plasma and white blood cell antioxidant enzyme activities of low birth weight infants receiving selenium supplemented and non-selenium supplemented parenteral nutrition from initiation of parenteral nutrition until discontinuation of preterm formula or hospital discharge.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 47
- Weight less than 1500 g at birth
- Not capable of receiving enteral feedings prior to 7 days postnatally
- Metabolic abnormalities such as inborn errors of metabolism
- Current viral infections
- Enterocolitis confirmed by diagnosis
- Presence of congenital anomalies, severe cardiac disease, liver disease, severe renal and neurological diseases, cholestasis, hemolytic disease and severe gastrointestinal disease
- Evidence of chronic white blood cell disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Serum Selenium Change from Baseline to Discharge (~50-60 days) 4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge
- Secondary Outcome Measures
Name Time Method Intake Change from study day 1 to study exit (~50-60 days) Daily recording of volume and calories from parenteral solutions and study formula consumed
Serum Copper Change from Baseline to Discharge (~50-60 days) 4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge
Serum Zinc Change from Baseline to Discharge (~50-60 days) 4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge
WBC Super oxide dismutase (SOD) activity Change from Baseline to Discharge (~50-60 days) 4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge
Glutathione peroxidase (GSHpx) activity Change from Baseline to Discharge (~50-60 days) 4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge
Plasma GSHpx activity Change from Baseline to Discharge (~50-60 days) 4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge
Plasma Amino Acid Concentrations Change from Baseline to Discharge (~50-60 days) 4 timepoints include 1) baseline prior to initiation of parenteral nutrition; 2) initiation of enteral nutrition; 3) at discontinuation of parenteral nutrition; 4) at discontinuation of preterm formula/discharge
Weight Change from study day 1 to study exit (~50-60 days) Weight at study day 1, at first enteral feed, at full enteral feeding, and at study exit
Length Change from study day 1 to study exit (~50-60 days) Length at study day 1, at first enteral feed, at full enteral feeding, and at study exit
Head Circumference Change from study day 1 to study exit (~50-60 days) Head circumference at study day 1, at first enteral feed, at full enteral feeding, and at study exit
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Legacy Emanuel Children's Hospital
🇺🇸Portland, Oregon, United States
Legacy Emanuel Children's Hospital🇺🇸Portland, Oregon, United States